Revenue

Annovis Bio's new trial for buntanetap uses an AI-powered Apple Watch app to track symptoms, aiming for more precise data in the race for a cure.

Crypto payments leader Mesh joins Canton Network as a Super Validator, bridging the gap between traditional and decentralized finance for institutional markets.

With a new CEO driven by a personal mission, Cylinder Health aims to scale its virtual care model in the booming, high-cost digestive health market.

Winamp's Bridger platform is expanding globally to collect offline royalties, aiming to fix a broken system and pay artists what they are owed.

The world's strongest coffee meets Hell's Kitchen's hero. See how this bold collaboration is brewing up more than just a morning cup of coffee.

LGM Pharma is investing $15 million to expand its Texas and Colorado sites, boosting domestic production of specialized drugs and fortifying the U.S. supply chain.

Sylogist reports strong SaaS revenue growth but an overall revenue decline and net loss, highlighting the high stakes of its ongoing business transformation.

A new app feature aims to combat costly workplace loneliness, but can a digital platform truly solve a deeply human problem of disconnection?

AI firm Corvex goes public via a merger with Movano, raising $40.2M to challenge cloud giants with its high-security GPU infrastructure platform.

A novel blood test from C2N Diagnostics, used in a major Alzheimer's trial, shows promise in predicting disease progression, heralding a new era of precision medicine.

Endevica Bio launches Kalohexis, a new biotech aiming to disrupt the obesity market with a drug that resets the body's 'metabolic thermostat'.

The logistics giant and Singapore's wealth fund are betting big on build-to-suit warehouses, signaling a major shift in supply chain strategy.

With a new CFO who helped steer a multi-billion dollar acquisition, Bambusa Therapeutics signals major growth plans for its innovative antibody platform.

A new report reveals a massive disparity in cloud firewall protection, with most failing to stop advanced evasion tactics, leaving enterprises exposed.

US magnet leader Permag is building a German factory to secure Europe's high-tech supply chains, a move to counter global risks and get closer to key customers.

The Ontario Real Estate Association is calling for a radical overhaul of development charges to tackle housing affordability. Will it work?

Junior explorer BULGOLD aims to advance its Lutila Gold Project with a new private placement, signaling confidence in its Central European gold strategy.

The toy giant's 600,000-square-foot facility is more than a warehouse; it's a key move in its plan for faster delivery and supply chain dominance.

A new biotech spins out with a novel drug class aiming to provide healthier, more durable weight loss and combat cancer-related wasting syndrome.

Cabrella and Complete Shipping Solutions' alliance shows how integrated tech and specialized insurance are driving growth and cutting losses in the 3PL space.